Tillement J‐P. A low distribution volume as a determinant of efficacy and safety for histamine (H1) antagonists.
No takes yet. Share an insight, caveat, or question.
Jean‐Paul Tillement (1995) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: